Bladder Cancer Lawsuit Filed By Firefighter Exposed To Toxic Film-Forming Foam

|

A California man has filed a product liability lawsuit over a bladder cancer diagnosis he indicates resulted from exposure to aqueous film-forming foams (AFFFs) used during his work as firefighter.

The complaint (PDF) was filed by Lon Holliday, Jr. in the U.S. District Court for the District of South Carolina on September 28, alleging that various manufacturers of the firefighting foam sold an unreasonably dangerous product and failed to warn firefighters about the toxic side effects.

The film-forming foams have been widely used in prior decades at military bases and by some civilian firefighting organizations during training exercises and in response to certain fuel-based fires. The toxic AFFF involved the use of per- and polyfluoroalkyl substances (PFAS), which are toxic and carcinogenic chemicals that are known to build up on the body and increase the risk of cancer and other health problems.

AFFF Cancer Lawsuit
AFFF Cancer Lawsuit

Holliday has named 3M Company, Buckeye Fire Equipment Company, Chemguard, Inc., Chemours Company, Chubb Fire, Ltd., Arkema, Inc., Du Pont De Nemours Inc., Kidde-Fenwal, Inc., Kidde, National Foam Inc. Tyco Fire Products, and others as defendants, indicating that each of the companies had a role in the production or sale of the toxic foam during the time he was exposed while working as a military or civilian firefighter.

“The Plaintiff directly used, was exposed, and/or was given AFFF to help fight fires on a regular basis,” Holliday’s complaint states. “The Plaintiff was never informed that this product was inherently dangerous. Nor was the Plaintiff warned about the known health risks associated with this product.”

The lawsuit indicates Holliday was diagnosed with bladder cancer, which was a direct result of exposure to the film-forming products sold by the defendants.

PFAS chemicals contained in AFFF are projected to take thousands of years to degrade, and past studies have shown their ability to enter and stay in the environment and human body through the air, dust, food, soil, and water. Previous U.S. Centers for Disease Control and Prevention (CDC) studies have shown PFAS chemicals primarily settle into the blood, kidney and liver, and could likely be detected in the blood of 98% of the U.S. population.

The toxic chemicals were first introduced into the manufacturing industry in the 1940’s, because of their ability to resist heat, grease, stains, and water. However, since then the chemicals have been linked to a myriad of adverse health effects including liver damage, thyroid disease, decreased fertility, high cholesterol, obesity, hormone suppression, and cancer.

The complaint joins other firefighting foam lawsuits, which have been filed over testicular cancer, kidney cancer, pancreatic cancer and other injuries.

Given common questions of fact and law raised in the litigation, all cases filed throughout the federal court system are currently centralized in the U.S. District Court for the District of South Carolina for coordinated discovery and pretrial proceedings.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera.
A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children.
Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer.